Sep 23, 2026 07:02AM
Sep 23, 2026 07:00AM
Jul 29, 2026 04:05PM
Jul 27, 2026 07:01AM
Jul 27, 2026 07:00AM
Jul 8, 2026 07:00AM
Jun 25, 2026 07:00AM Glaukos completes enrollment in Phase 2 eye disease drug study
Jun 25, 2026 07:00AM
May 12, 2026 07:00AM
Apr 29, 2026 04:05PM
Apr 16, 2026 07:00AM
Apr 15, 2026 04:05PM
Apr 15, 2026 04:05PM
Apr 8, 2026 07:00AM Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29
Apr 6, 2026 07:00AM
Mar 19, 2026 07:00AM
Feb 17, 2026 04:05PM
Jan 28, 2026 09:05AM
Jan 28, 2026 07:01AM
Jan 28, 2026 07:00AM
Jan 20, 2026 07:00AM Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
Jan 13, 2026 04:06PM
Jan 13, 2026 04:05PM
Dec 16, 2025 07:00AM
Nov 3, 2025 07:00AM
Oct 29, 2025 04:05PM
Oct 20, 2025 07:00AM
Oct 20, 2025 07:00AM Glaukos Announces FDA Approval of Epioxa™
Oct 14, 2025 07:00AM
Oct 8, 2025 07:00AM
Sep 25, 2025 04:05PM
Sep 25, 2025 04:05PM
Aug 13, 2025 07:00AM
Jul 30, 2025 04:05PM
Jul 9, 2025 07:00AM Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30
Jun 30, 2025 07:38AM
Jun 25, 2025 04:05PM
Jun 25, 2025 04:05PM
Jun 25, 2025 07:00AM
May 13, 2025 07:00AM
May 1, 2025 07:37AM
Apr 30, 2025 04:05PM Glaukos Announces First Quarter 2025 Financial Results
Apr 23, 2025 07:00AM
Apr 16, 2025 07:00AM
Apr 9, 2025 07:00AM
Mar 11, 2025 07:00AM
Feb 24, 2025 07:01AM
Feb 24, 2025 07:00AM
Feb 20, 2025 04:05PM Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results
Jan 23, 2025 07:00AM

331,769 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All